EICHORCondition: Spinal Muscular Atrophy (SMA) · Sponsor: Novartis Pharmaceuticals
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a global, prospective, multi-center study that is designed to assess the long-term safety and efficacy of OAV101 in patients who participated in an OAV101 clinical trial. The assessments of safety and efficacy in Study COAV101A12308 will continue for 5 years after enrollment in this study.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: 1. Participated in an OAV101 clinical trial. 2. Written informed consent must be obtained before any assessment is performed. 3. Patient/Parent/legal guardian willing and able to comply with study procedures. Exclusion Criteria: There are no exclusion criteria for this study.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Child Hosp Of The Kings Daughters | Norfolk, Virginia, United States | — |
| Novartis Investigative Site | Sydney, New South Wales, Australia | — |
| Novartis Investigative Site | Leuven, Belgium | — |
| Novartis Investigative Site | Curitiba, Paraná, Brazil | — |
| Novartis Investigative Site | São Paulo, São Paulo, Brazil | — |
| Novartis Investigative Site | Montreal, Quebec, Canada | — |
| Novartis Investigative Site | Chongqing, Chongqing Municipality, China | — |
| Novartis Investigative Site | Guangzhou, Guangdong, China | — |
| Novartis Investigative Site | Chengdu, Sichuan, China | — |
| Novartis Investigative Site | Beijing, China | — |
| Novartis Investigative Site | Beijing, China | — |
| Novartis Investigative Site | Beijing, China | — |
+ 20 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05335876